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with a blower mister, because other mechanisms like crossclamp-
ing or cannulation of the ascending aorta bear a stroke risk of more
than 8% in octogenarians3 and may have been the cause for
emboli. However, we cannot rule out that air provided by the
blower mister device entered the aorta through a leak between the
proximal seal and the aortic wall and caused the emboli. The
possibility of such a mechanism was proven in an animal experi-
ment. This should be sufficient reason to strongly discourage the
simultaneous use of the HEARTSTRING device in combination
with a blower mister.
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Life-threatening anaphylactic shock caused by porcine heparin
intravenous infusion during mitral valve repair
Tomaso Bottio, MD,a Giorgio Pittarello, MD,b Raffaele Bonato, MD,b Umberto Fagiolo, MD,c and Gino Gerosa, MD,a
Padua, Italy
Adverse skin reactions to low-molecular-weight hepa-rin and systemic allergic reactions coupled with hep-arin-induced antibody reactions have been de-scribed.1-3 In this report we describe a case of
cardiogenic anaphylactic shock caused by porcine gut heparin
infusion in the cardiac surgery theater before starting cardiopul-
monary bypass (CPB) in a young man with degenerative mitral
valve incompetence.
Clinical Summary
A 36-year-old man was referred to the Cardiovascular Institute of
Padua University for mitral valve repair of valve incompetence
caused by a floppy valve. He had a history for asthma treated with
-stimulants and a documented Acarus species allergy. He had
mitral valve incompetence for about 6 years, which more recently
progressed to New York Heart Association class II. Physical
examination revealed significant systolic murmur (5/6 grade).
Electrocardiography disclosed normal sinus rhythm (97 beats/
min), mild left ventricular hypertrophy, and an enlarged atrial
component. The hematologic and biochemical values were within
normal range. Chest radiography showed an increased cardiotho-
racic ratio. Two-dimensional echocardiography showed severe
mitral regurgitation and left
atrial and ventricular dilata-
tion with a normal ejection
fraction. These data were
confirmed by cardiac angiog-
raphy with hemodynamic
study. The spirometry analy-
sis showed mild airways ob-
struction with reduced tidal
volume.
After providing written
informed consent, the patient
received premedication con-
sisting of 2 mg of oral loraz-
epam administered 1 hour be-
fore the start of anesthesia.
The patient was prepared by
introduction of an intrave-
nous catheter in the right arm for balanced salt solution infusion
and an arterial catheter with local anesthesia in the left radial artery
for continuous blood pressure monitoring.
Monitoring also included electrocardiographic leads II and V5
with automated ST-segment analysis and trending, pulse oximetry,
and capnography. After a 5-minute preoxygenation period, general
anesthesia was induced with thiopental (2.5 mg/kg), followed by
fentanyl (5 g/kg) and vecuronium (0.1 mg/kg). After loss of
consciousness, mask ventilation was maintained with 100% oxy-
gen, and 2 minutes later, an endotracheal tube was introduced.
Mechanical ventilation with a mixture of oxygen-air (60%) was
adjusted to maintain end-tidal carbon dioxide between 30 and 35
mm Hg, with an airway peak pressure of less than 25 mm Hg and
a normal capnography curve. Maintenance of anesthesia was
achieved with fentanyl up to 20 g/kg before sternotomy and with
a continuous infusion of propofol (3 mg  kg1  h1) and cisa-
tracurium (1.5 g  kg1  min1). Intravenous antibiotic prophy-
laxis (cephazolin, 30 mg/kg) was given. After induction of anes-
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thesia, an internal jugular vein was cannulated for drug infusion
and central venous pressure monitoring.
Before administration of intravenous heparin, no adverse
events with hemodynamic or respiratory alterations were observed,
and there was an absence of skin reactions of every type, even after
antibiotic therapy.
Before the start of CPB, a complete dose of porcine gut heparin
(300 IU/kg1; Epsoclar; Biologici Italia Laboratories S.r.l.) was
administered. Immediately thereafter, the blood pressure decreased
from 130/60 to 30/10 mm Hg, despite infusion of metaraminol,
epinephrine, norepinephrine, methylprednisolone, and salbutamol.
An airway stoppage without the possibility of mechanical venti-
lation occurred despite tracheobronchial puffs of epinephrine and
ipratropium, and 2 minutes later, the heart had fibrillated. In
emergency status the blood flow was restored during CPB. At
tracheobronchoscopy, the mucus membrane of the airways seemed
edematous, and the lumen seemed virtual. The patient was oper-
ated on with a continuous infusion of epinephrine to maintain an
adequate mean blood pressure; moderate hypothermia; cardiople-
gic arrest with cold blood intermittent, antegrade, and retrograde
cardioplegia; and additional topical cooling with ice slush. The
native mitral valve was repaired by means of posterior leaflet
rectangular resection reinforced by a Carpentier ring (30 mm)
implanted with single stitches. The patient was weaned from CPB
smoothly after restoring an acceptable ventilation with intravenous
infusion of methylprednisolone (1 mg/kg per dose), salbutamol
(0.5 g  kg1  min1), and dopamine (4 g  kg1  min1).
The patient was extubated in the intensive care unit 8 hours
later, and he was discharged on the third postoperative day on a
regimen of oral anticoagulation (warfarin) without antiplatelet
therapy. The patient was discharged home free of cardiac and
breathing symptoms, intravenous salbutamol was translated to
puff, and methylprednisolone was discontinued. Thrombocytope-
nia was never observed in this patient.
Oral anticoagulation was discontinued 3 months after the op-
eration, as is our protocol with mitral valve repair. Two months
later, after all drug intake had been interrupted (oral anticoagu-
lants, angiotensin-converting enzyme inhibitors), the patient un-
derwent skin prick testing for allergic sensitization measurement.
The results were compared with those of 9 patients followed for
sensitization to common environmental allergens. Skin testing was
performed by the same individual using porcine gut heparin at
growing dilution. Skin reactivity was observed only in our patient,
and he had positive results for even the highest dilution.
Discussion
We have reported a life-threatening case of unexpected and irre-
versible cardiac shock, despite immediate drug administration,
after full heparinization and before commencing CPB.
Anaphylactic reactions were already noted and reported in the
clinical setting in the early phase of heparin use.4 Today, because
the purified heparin was introduced in clinical use, cases of porcine
heparin anaphylactic reaction have been observed only rarely.3,5
In the English-language literature a fatal case caused by heparin
reaction was described by Ansell and colleagues6 in 1986. During
a cardiac operation, Harada and coworkers3 reported on a 7-year-
old girl with reactions similar to those of our patient caused by
heparinized saline solution being used to flush the radial artery. In
that case the pressure decreased from 130/90 to 60/0 mm Hg.
The peculiarity of what we are reporting is the systemic reac-
tion with circulatory collapse and airway blockage despite the
massive drug attack with catecholamine, steroids, and -stimu-
lants. The only choice we had to save the patient’s life was to start
CPB in overflow (130%), reducing the body temperature (28°C) to
ensure a mean arterial pressure of at least 50 mm Hg with 100%
oxygen fraction because of the contemporaneous airway ventila-
tion arrest. We decided at this point, with an activated clotting time
of 420 seconds, to operate on the patient. The mitral valve was
repaired, and the patient was carefully weaned from CPB sup-
ported with a continuous infusion of catecholamine and steroid
coupled with salbutamol for airway ventilation.
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